Myriad Genetics, Inc. (MYGN)
3.16
-0.07
(-2.17%)
USD |
NASDAQ |
Sep 04, 13:16
Myriad Genetics Cash and Short Term Investments (Quarterly) : 115.20M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 115.20M |
| March 31, 2026 | 124.40M |
| December 31, 2025 | 149.60M |
| September 30, 2025 | 145.40M |
| June 30, 2025 | 74.40M |
| March 31, 2025 | 91.80M |
| December 31, 2024 | 111.00M |
| September 30, 2024 | 99.90M |
| June 30, 2024 | 97.30M |
| March 31, 2024 | 104.30M |
| December 31, 2023 | 142.10M |
| September 30, 2023 | 86.30M |
| June 30, 2023 | 121.60M |
| March 31, 2023 | 78.70M |
| December 31, 2022 | 116.90M |
| September 30, 2022 | 193.20M |
| June 30, 2022 | 205.10M |
| March 31, 2022 | 268.40M |
| December 31, 2021 | 339.80M |
| September 30, 2021 | 366.10M |
| June 30, 2021 | 164.40M |
| March 31, 2021 | 176.10M |
| June 30, 2020 | 217.80M |
| March 31, 2020 | 181.50M |
| December 31, 2019 | 141.60M |
| Date | Value |
|---|---|
| September 30, 2019 | 142.60M |
| June 30, 2019 | 136.90M |
| March 31, 2019 | 149.70M |
| December 31, 2018 | 165.40M |
| September 30, 2018 | 167.50M |
| June 30, 2018 | 180.60M |
| March 31, 2018 | 157.30M |
| December 31, 2017 | 143.50M |
| September 30, 2017 | 148.30M |
| June 30, 2017 | 150.70M |
| March 31, 2017 | 172.10M |
| December 31, 2016 | 162.50M |
| September 30, 2016 | 148.40M |
| June 30, 2016 | 159.00M |
| March 31, 2016 | 216.70M |
| December 31, 2015 | 219.30M |
| September 30, 2015 | 155.40M |
| June 30, 2015 | 144.80M |
| March 31, 2015 | 134.43M |
| December 31, 2014 | 187.25M |
| September 30, 2014 | 182.28M |
| June 30, 2014 | 186.46M |
| March 31, 2014 | 212.16M |
| December 31, 2013 | 353.60M |
| September 30, 2013 | 357.02M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Natera, Inc. | 1.092B |
| Sera Prognostics, Inc. | 46.44M |
| BioRestorative Therapies, Inc. | 3.592M |
| CareDx, Inc. | 373.64M |
| Exagen, Inc. | 24.59M |